|
16
|
|
Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy.
(nature.com)
|
Tan TS
…
Lichterfeld M
Nature Immunology
2026-09-01
|
#hiv
#immunity
#reservoir
#nk cells
|
|
9
|
|
Quantifying how HIV-1 envelope sequence features impact vaccine efficacy in the HVTN 705/HPX2008 randomised trial in southern African women.
(linkinghub.elsevier.com)
|
Juraska M
…
Mullins JI
EBioMedicine
2026-08-31
|
#vaccination
#hiv
#sequencing
#neutralizing-antibodies
#immunogenicity
|
|
7
|
|
Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience.
(academic.oup.com)
|
Havens JP
…
Bares SH
Clinical Infectious Diseases
2026-09-01
|
#hiv
#pharmacoeconomics
#implementation
|
|
7
|
|
Direct Initiation of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV and Suboptimal Virologic Suppression: A Randomized Trial.
(academic.oup.com)
|
Chen NY
…
Cheng CY
Clinical Infectious Diseases
2026-09-01
|
#hiv
#viremia
#adherence
#suppression
|
|
4
|
|
Latent tuberculosis infection shapes gut microbiome and immune-metabolic interactions in people living with HIV.
(tandfonline.com)
|
Devadiga P
…
Bhor VM
Gut Microbes
2026-08-27
|
#microbiome
#tb
#hiv
#dysbiosis
#metagenomics
|
|
4
|
|
A novel biomarker signature based on circulating transfer RNA (tRNA) can detect and differentiate HIV-2 infection from HIV-1.
(journals.asm.org)
|
Biswas S
…
Devadas K
Journal of Clinical Microbiology
2026-08-31
|
#biomarker
#hiv
#transcriptomics
#diagnostics
|
|
4
|
|
An optimized product-enhanced reverse transcriptase assay for sensitive and quantitative detection of HIV viral load and phenotypic drug resistance.
(journals.asm.org)
|
Mims DK
…
Olanrewaju AO
Journal of Clinical Microbiology
2026-08-31
|
#hiv
#amr
#phenotyping
#viral-load
#qpcr
|
|
4
|
|
Prospects of HIV elimination among men who have sex with men: A systematic review of modeling studies.
(journals.plos.org)
|
Roberts JA
…
Rozhnova G
PLOS Computational Biology
2026-08-31
|
#modeling
#hiv
#elimination
#transmission
#intervention
|
|
3
|
|
Dose-ranging pharmacokinetics, safety, and efficacy of a 90-day intravaginal ring delivering islatravir in pigtail macaques.
(science.org)
|
Srinivasan P
…
Smith JM
Science Advances
2026-08-26
|
#pharmacokinetics
#hiv
#drug delivery
#prevention
#preclinical
|
|
2
|
|
Immune control of HIV viraemia in early paediatric infection is associated with induction of HIV-specific CD8+ T-cell activity following multiple treatment interruptions.
(academic.oup.com)
|
Edgar JE
…
Goulder P
Journal of Infectious Diseases
2026-08-29
|
#hiv
#immunity
#pediatric
#viremia
#cd8
|
|
2
|
|
Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial.
(linkinghub.elsevier.com)
|
Mboizi R
…
Le Doaret K
Lancet Infectious Diseases
2026-08-25
|
#vaccination
#immunogenicity
#pregnancy
#hiv
#streptococcus
|
|
1
|
|
Long-term treatment durability and safety after switching to bictegravir/emtricitabine/tenofovir alafenamide in real-world practice: a 144-week update from the BICTEL cohort.
(linkinghub.elsevier.com)
|
Bortolani L
…
d'Ettorre G
International Journal of Antimicrobial Agents
2026-08-28
|
#hiv
#adherence
#safety
#cohort study
|
|
1
|
|
When Choosing Antiretroviral Therapy Meets Immigration Policy: An Ethical Analysis.
(academic.oup.com)
|
Diarra A
…
de Bouille JG
Clinical Infectious Diseases
2026-08-25
|
#hiv
#ethics
#migration
#adherence
|
|
1
|
|
HPV vaccine effectiveness against prevalent HPV by age, years sexually active before vaccination, and HIV status in gay, bisexual, and other men who have sex with men, 2019-2021.
(academic.oup.com)
|
Khayargoli P
…
Burchell AN
Journal of Infectious Diseases
2026-08-26
|
#vaccination
#hpv
#epidemiology
#hiv
#prevalence
|
|
0
|
|
Concordance Between Fingerprick and Venous Whole Blood CD4 Counts Using the Visitect CD4 Advanced disease platform.
(academic.oup.com)
|
Adzemovic T
…
Rajasingham R
Journal of Infectious Diseases
2026-08-24
|
#immunology
#diagnostics
#hiv
#point-of-care
|
|
0
|
|
Fc-engineered broadly neutralizing antibodies overcome cytokine-induced CD16 cleavage to drive potent ADCC against diverse HIV-1 strains.
(journals.asm.org)
|
Melo C
…
Bosque A
mBio
2026-08-21
|
#antibody
#hiv
#immunotherapy
#cytotoxicity
#exhaustion
|
|
0
|
|
The applicability of DNA methylation-based tools in a low-income, sub-Saharan African population: Malawi longitudinal study of families and health.
(linkinghub.elsevier.com)
|
Zhuang BC
…
Kohler HP
iScience
2026-08-21
|
#epigenetics
#methylation
#biomarker
#aging
#hiv
|
|
0
|
|
The immunophenotype and proviral landscape of HIV-infected CD4 T cells during antiretroviral therapy.
(pnas.org)
|
Delley CL
…
Clark IC
PNAS
2026-08-18
|
#hiv
#reservoir
#immunophenotype
#sequencing
#cd4
|
|
0
|
|
Annual vs semi-annual follow-up in low complexity virologically suppressed people with HIV: a randomized interventional trial.
(academic.oup.com)
|
Chivite I
…
Laguno M
Clinical Infectious Diseases
2026-08-19
|
#hiv
#virological
#clinical trial
#adherence
#suppression
|
|
0
|
|
Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.
(linkinghub.elsevier.com)
|
Colson AE
…
Ogbuagu O
The Lancet
2026-08-12
|
#hiv
#clinical trial
#virological suppression
|